tadalafil 2.5 MG Oral Tablet
- RxCUI
- 757707
- RxNorm name
- tadalafil 2.5 MG Oral Tablet
- Display name
- tadalafil 2.5 MG Oral Tablet
- Full name
- tadalafil 2.5 MG Oral Tablet
- Term type
- SCD
- Status
- DailyMed mapping
- Updated
- 2026-06-04 23:38:46
UNII Substances#
No records found.
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Tadalafil | TADALAFIL | NuCare Pharmaceuticals,Inc. | 0a9cf85a-c17d-6890-e063-6394a90a93e9 | 2025-03-04 | Warnings, Adverse reactions | 757707 |
| TADALAFIL | TADALAFIL | NuCare Pharmaceuticals, Inc. | 2eae8756-5c7f-2545-e063-6294a90a6d52 | 2025-02-21 | Warnings, Adverse reactions | 757707 |
| Tadalafil | TADALAFIL | Alembic Pharmaceuticals Inc. | abcb2cda-9b3f-45f6-ad5f-c2370b0dd114 | 2025-02-03 | Warnings, Adverse reactions | 757707 |
| Tadalafil | TADALAFIL | XLCare Pharmaceuticals Inc. | add6afb8-d38c-47a2-8c35-d5940667bb0c | 2024-12-09 | Warnings, Adverse reactions | 757707 |
| Tadalafil | TADALAFIL | Alembic Pharmaceuticals Limited | 741102c1-8809-44d4-9098-3dc8c0604764 | 2024-09-05 | Warnings, Adverse reactions | 757707 |
| Tadalafil | TADALAFIL | Zydus Lifesciences Limited | 6c1c3a1f-80a4-417c-8830-5edbb9a0710f | 2024-08-12 | 757707 | |
| Tadalafil | TADALAFIL | Aurobindo Pharma Limited | 0345b81b-f946-4dd6-b49d-2a2bdd4c49c9 | 2024-05-24 | Warnings, Adverse reactions | 757707 |
| tadalafil | TADALAFIL | Unichem Pharmaceuticals (USA), Inc. | a7b3937e-ff03-436a-a5d4-92a4771034b6 | 2024-01-31 | Warnings, Adverse reactions | 757707 |
| Tadalafil | TADALAFIL | NorthStar RxLLC | 594acc15-a5bc-43b5-9659-a864b2c46eea | 2023-11-10 | Warnings, Adverse reactions | 757707 |
| Tadalafil | TADALAFIL | Zydus Pharmaceuticals USA Inc. | cfe43ab8-8721-4db8-8810-f0072cf8f4d3 | 2023-11-08 | Warnings, Adverse reactions | 757707 |
| Tadalafil | TADALAFIL | Sun Pharmaceutical Industries, Inc. | 168a135b-1454-4def-9b03-c9a470bfcb5f | 2023-10-10 | Warnings, Adverse reactions | 757707 |
| Tadalafil | TADALAFIL | Asclemed USA, Inc. | 5ea24573-2d16-40d8-a46c-7b5fa8669e69 | 2023-03-28 | Warnings, Adverse reactions | 757707 |
| Tadalafil | TADALAFIL | Asclemed USA, Inc. | 30ae58ed-5b56-4513-8eb3-eb4f89b78f9d | 2023-03-22 | Warnings, Adverse reactions | 757707 |
| tadalafil | TADALAFIL | Burel Pharmaceuticals, LLC | a2e7f393-5cfc-45e5-b87d-9e8abc8e4355 | 2022-12-01 | Warnings, Adverse reactions | 757707 |
| Tadalafil | TADALAFIL | Qilu Pharmaceutical Co., Ltd. | f295f164-78fb-4224-b319-9f20b7a453b5 | 2021-11-17 | Warnings, Adverse reactions | 757707 |
| tadalafil | TADALAFIL | VKT Pharma Private Limited | b4d9851c-5c06-4532-bd82-16d92b60c28f | 2021-11-17 | Warnings, Adverse reactions | 757707 |
| Tadalafil | TADALAFIL | Dr.Reddys Laboratories Inc | 22b8a2e3-d1b8-f193-45fa-77cc62a1b941 | 2020-01-30 | Warnings, Adverse reactions | 757707 |
| Tadalafil | TADALAFIL | Amneal Pharmaceuticals NY LLC | 2cad2167-dbd1-4df8-b407-b270487d027b | 2019-10-25 | Warnings, Adverse reactions | 757707 |
| Tadalafil | TADALAFIL | Camber Pharmaceuticals, Inc. | a3892605-4eb1-4d6e-a675-f7f7d4302f38 | 2019-03-26 | Warnings, Adverse reactions | 757707 |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.
DailyMed RxNorm Mappings#
| Set ID | RxNorm mappings | Terms | SPL version | Label | Effective |
|---|---|---|---|---|---|
| 07567ae5-7345-4ab1-9b2c-c586c4da0427 | tadalafil 2.5 MG Oral Tablet [PSN] · tadalafil 2.5 MG Oral Tablet [SCD] | 2 | 105 | These highlights do not include all the information needed to use TADALAFIL TABLETS safely and effectively. See full prescribing information for TADALAFIL TABLETS. TADALAFIL tablets, for oral use Initial U.S. Approval: 2003 | 20260407 |
| 2c2ec257-06bc-4ca4-9cf3-d0f49980e374 | tadalafil 2.5 MG Oral Tablet [PSN] · tadalafil 2.5 MG Oral Tablet [SCD] | 2 | 103 | These highlights do not include all the information needed to use TADALAFIL TABLETS safely and effectively. See full prescribing information for TADALAFIL TABLETS. TADALAFIL tablets, for oral use Initial U.S. Approval: 2003 | 20260514 |
| b3a58c17-f260-4125-abd1-27da00bb0719 | tadalafil 2.5 MG Oral Tablet [PSN] · tadalafil 2.5 MG Oral Tablet [SCD] | 2 | 102 | These highlights do not include all the information needed to use TADALAFIL TABLETS safely and effectively. See full prescribing information for TADALAFIL TABLETS. TADALAFIL tablets for oral use. Initial U.S. Approval: 2003 | 20260529 |
| eedf3ad9-7d40-496d-b1a9-6200010c18e1 | tadalafil 2.5 MG Oral Tablet [PSN] · tadalafil 2.5 MG Oral Tablet [SCD] | 2 | 15 | These highlights do not include all the information needed to use TADALAFIL TABLETS safely and effectively. See full prescribing information for TADALAFIL TABLETS. TADALAFIL tablets, for oral use Initial U.S. Approval: 2003 | 20260416 |
| abcb2cda-9b3f-45f6-ad5f-c2370b0dd114 | tadalafil 2.5 MG Oral Tablet [PSN] · tadalafil 2.5 MG Oral Tablet [SCD] | 2 | 14 | These highlights do not include all the information needed to use TADALAFIL TABLETS safely and effectively. See full prescribing information for TADALAFIL TABLETS. TADALAFIL tablets, for oral use Initial U.S. Approval: 2003 | 20250203 |
| a7b3937e-ff03-436a-a5d4-92a4771034b6 | tadalafil 2.5 MG Oral Tablet [PSN] · tadalafil 2.5 MG Oral Tablet [SCD] | 2 | 13 | These highlights do not include all the information needed to use TADALAFIL TABLETS safely and effectively. See full prescribing information for TADALAFIL TABLETS. TADALAFIL Tablets, for oral use Initial U.S. Approval: 2003 | 20240131 |
| 7e4cdac1-42cc-4038-a86b-4890962ed806 | tadalafil 2.5 MG Oral Tablet [PSN] · tadalafil 2.5 MG Oral Tablet [SCD] | 2 | 12 | These highlights do not include all the information needed to use TADALAFIL TABLETS safely and effectively. See full prescribing information for TADALAFIL TABLETS. TADALAFIL tablets, for oral use Initial U.S. Approval: 2003 | 20251010 |
| 3ea7612b-b004-43ef-accc-34c8ec5146b8 | tadalafil 2.5 MG Oral Tablet [PSN] · tadalafil 2.5 MG Oral Tablet [SCD] | 2 | 11 | These highlights do not include all the information needed to use TADALAFIL TABLETS safely and effectively. See full prescribing information for TADALAFIL TABLETS. TADALAFIL tablets, for oral use Initial U.S. Approval: 2003 | 20260305 |
| ca1d46e3-ad9b-48c7-bb7f-63ee678ccf7a | tadalafil 2.5 MG Oral Tablet [PSN] · tadalafil 2.5 MG Oral Tablet [SCD] | 2 | 10 | These highlights do not include all the information needed to use TADALAFIL TABLETS safely and effectively. See full prescribing information for TADALAFIL TABLETS. TADALAFIL tablets, for oral use Initial U.S. Approval: 2003 | 20251209 |
| 90f38460-62ad-492e-a3da-403d5a5a5d86 | tadalafil 2.5 MG Oral Tablet [PSN] · tadalafil 2.5 MG Oral Tablet [SCD] | 2 | 8 | These highlights do not include all the information needed to use TADALAFIL TABLETS safely and effectively. See full prescribing information for TADALAFIL TABLETS. TADALAFIL tablets, for oral use Initial U.S. Approval: 2003 | 20260415 |
| f295f164-78fb-4224-b319-9f20b7a453b5 | tadalafil 2.5 MG Oral Tablet [PSN] · tadalafil 2.5 MG Oral Tablet [SCD] | 2 | 8 | These highlights do not include all the information needed to use TADALAFIL TABLETS safely and effectively. See full prescribing information for TADALAFIL TABLETS. TADALAFIL Tablets, for oral use Initial U.S. Approval: 2003 | 20211117 |
| 22b8a2e3-d1b8-f193-45fa-77cc62a1b941 | tadalafil 2.5 MG Oral Tablet [PSN] · tadalafil 2.5 MG Oral Tablet [SCD] | 2 | 8 | These highlights do not include all the information needed to use TADALAFIL TABLETS safely and effectively. See full prescribing information for TADALAFIL TABLETS. TADALAFIL tablets, for oral use Initial U.S. Approval: 2003 | 20200130 |
| 05640a4d-afb7-42ae-a5bb-77dbc8412356 | tadalafil 2.5 MG Oral Tablet [PSN] · tadalafil 2.5 MG Oral Tablet [SCD] | 2 | 6 | These highlights do not include all the information needed to use TADALAFIL TABLETS safely and effectively. See full prescribing information for TADALAFIL TABLETS. TADALAFIL tablets, for oral use Initial U.S. Approval: 2003 | 20250831 |
| 0345b81b-f946-4dd6-b49d-2a2bdd4c49c9 | tadalafil 2.5 MG Oral Tablet [PSN] · tadalafil 2.5 MG Oral Tablet [SCD] | 2 | 6 | These highlights do not include all the information needed to use TADALAFIL TABLETS safely and effectively. See full prescribing information for TADALAFIL TABLETS. TADALAFIL tablets, for oral use Initial U.S. Approval: 2003 | 20240524 |
| 168a135b-1454-4def-9b03-c9a470bfcb5f | tadalafil 2.5 MG Oral Tablet [PSN] · tadalafil 2.5 MG Oral Tablet [SCD] | 2 | 6 | These highlights do not include all the information needed to use TADALAFIL TABLETS safely and effectively. See full prescribing information for TADALAFIL TABLETS. TADALAFIL tablets, for oral use Initial U.S. Approval: 2003 | 20231010 |
| ee053358-9746-4475-9d3d-ca83ea84c125 | tadalafil 2.5 MG Oral Tablet [PSN] · tadalafil 2.5 MG Oral Tablet [SCD] | 2 | 6 | These highlights do not include all the information needed to use CIALIS safely and effectively. See full prescribing information for CIALIS. CIALIS (tadalafil) tablets, for oral use Initial U.S. Approval: 2003 | 20190221 |
| 78509a43-a907-4359-9022-f38c4f765880 | tadalafil 2.5 MG Oral Tablet [PSN] · tadalafil 2.5 MG Oral Tablet [SCD] | 2 | 5 | These highlights do not include all the information needed to use TADALAFIL TABLETS safely and effectively. See full prescribing information for TADALAFIL TABLETS. TADALAFIL tablets, for oral use Initial U.S. Approval: 2003 | 20260204 |
| 741102c1-8809-44d4-9098-3dc8c0604764 | tadalafil 2.5 MG Oral Tablet [PSN] · tadalafil 2.5 MG Oral Tablet [SCD] | 2 | 5 | These highlights do not include all the information needed to use TADALAFIL TABLETS safely and effectively. See full prescribing information for TADALAFIL TABLETS. TADALAFIL tablets, for oral use Initial U.S. Approval: 2003 | 20240905 |
| a0f728b6-2cc6-cb65-e053-2a95a90ab142 | tadalafil 2.5 MG Oral Tablet [PSN] · tadalafil 2.5 MG Oral Tablet [SCD] | 2 | 4 | These highlights do not include all the information needed to use TADALAFIL TABLETS safely and effectively. See full prescribing information for TADALAFIL TABLETS. Tadalafil tablets, for oral use Initial U.S. Approval: 2003 | 20260305 |
| b96ae7f1-7d4a-a211-e053-2995a90ab6e2 | tadalafil 2.5 MG Oral Tablet [PSN] · tadalafil 2.5 MG Oral Tablet [SCD] | 2 | 4 | TADALAFIL tablets, for oral use These highlights do not include all the information needed to use TADALAFIL TABLETS safely and effectively. See full prescribing information for TADALAFIL TABLETS. Initial U.S. Approval: 2003 | 20260116 |
| 4348b7db-e5b2-4e87-8cdd-674797a18890 | tadalafil 2.5 MG Oral Tablet [PSN] · tadalafil 2.5 MG Oral Tablet [SCD] | 2 | 4 | These highlights do not include all the information needed to use TADALAFIL TABLETS safely and effectively. See full prescribing information for TADALAFIL TABLETS. TADALAFIL tablets, for oral use Initial U.S. Approval: 2003 | 20250917 |
| 6c1c3a1f-80a4-417c-8830-5edbb9a0710f | tadalafil 2.5 MG Oral Tablet [PSN] · tadalafil 2.5 MG Oral Tablet [SCD] | 2 | 4 | TADALAFIL TABLETS | 20240812 |
| cfe43ab8-8721-4db8-8810-f0072cf8f4d3 | tadalafil 2.5 MG Oral Tablet [PSN] · tadalafil 2.5 MG Oral Tablet [SCD] | 2 | 4 | These highlights do not include all the information needed to use TADALAFIL TABLETS safely and effectively. See full prescribing information for TADALAFIL TABLETS. TADALAFIL tablets, for oral use Initial U.S. Approval: 2003 | 20231108 |
| a2e7f393-5cfc-45e5-b87d-9e8abc8e4355 | tadalafil 2.5 MG Oral Tablet [PSN] · tadalafil 2.5 MG Oral Tablet [SCD] | 2 | 4 | These highlights do not include all the information needed to use TADALAFIL TABLETS safely and effectively. See full prescribing information for TADALAFIL TABLETS. TADALAFIL tablets, for oral use Initial U.S. Approval: 2003 | 20221201 |
| 83040eb4-e541-499a-ae63-36534e31a94c | tadalafil 2.5 MG Oral Tablet [PSN] · tadalafil 2.5 MG Oral Tablet [SCD] | 2 | 4 | These highlights do not include all the information needed to use tadalafil safely and effectively. See full prescribing information for tadalafil. Tadalafil Tablets, for oral use Initial U.S. Approval: 2003 | 20190221 |
| ae801b15-0462-44af-99a4-affe3eed899a | tadalafil 2.5 MG Oral Tablet [PSN] · tadalafil 2.5 MG Oral Tablet [SCD] | 2 | 3 | These highlights do not include all the information needed to use TADALAFIL TABLETS safely and effectively. See full prescribing information for TADALAFIL TABLETS. TADALAFIL tablets, for oral use Initial U.S. Approval: 2003 | 20260116 |
| 2cad2167-dbd1-4df8-b407-b270487d027b | tadalafil 2.5 MG Oral Tablet [PSN] · tadalafil 2.5 MG Oral Tablet [SCD] | 2 | 3 | These highlights do not include all the information needed to use TADALAFIL TABLETS safely and effectively. See full prescribing information for TADALAFIL TABLETS. TADALAFIL tablets, for oral use Initial U.S. Approval: 2003 | 20191025 |
| 6caf3b55-9bf4-4355-9e25-8bf368943fdd | tadalafil 2.5 MG Oral Tablet [PSN] · tadalafil 2.5 MG Oral Tablet [SCD] | 2 | 2 | These highlights do not include all the information needed to use TADALAFIL TABLETS safely and effectively. See full prescribing information for TADALAFIL TABLETS. TADALAFIL tablets, for oral use Initial U.S. Approval: 2003 | 20260426 |
| 0ea97208-5afc-4943-b35c-ea850203a794 | tadalafil 2.5 MG Oral Tablet [PSN] · tadalafil 2.5 MG Oral Tablet [SCD] | 2 | 2 | These highlights do not include all the information needed to use TADALAFIL TABLETS safely and effectively. See full prescribing information for TADALAFIL TABLETS. TADALAFIL tablets, for oral use Initial U.S. Approval: 2003 | 20251219 |
| fa547e3d-455a-4926-9fd9-349930898502 | tadalafil 2.5 MG Oral Tablet [PSN] · tadalafil 2.5 MG Oral Tablet [SCD] | 2 | 2 | These highlights do not include all the information needed to use TADALAFIL TABLETS safely and effectively. See full prescribing information for TADALAFIL TABLETS. TADALAFIL Tablets, for oral use Initial U.S. Approval: 2003 | 20250625 |
| 491cb72b-71f2-4df9-99f8-c02d93500103 | tadalafil 2.5 MG Oral Tablet [PSN] · tadalafil 2.5 MG Oral Tablet [SCD] | 2 | 2 | These highlights do not include all the information needed to use TADALAFIL TABLETS safely and effectively. See full prescribing information for TADALAFIL TABLETS. TADALAFIL tablets, for oral use Initial U.S. Approval: 2003 | 20250331 |
| 0a9cf85a-c17d-6890-e063-6394a90a93e9 | tadalafil 2.5 MG Oral Tablet [PSN] · tadalafil 2.5 MG Oral Tablet [SCD] | 2 | 2 | These highlights do not include all the information needed to use TADALAFIL TABLETS safely and effectively. See full prescribing information for TADALAFIL TABLETS. TADALAFIL tablets, for oral use Initial U.S. Approval: 2003 | 20250304 |
| 594acc15-a5bc-43b5-9659-a864b2c46eea | tadalafil 2.5 MG Oral Tablet [PSN] · tadalafil 2.5 MG Oral Tablet [SCD] | 2 | 2 | These highlights do not include all the information needed to use TADALAFIL TABLETS safely and effectively. See full prescribing information for TADALAFIL TABLETS. TADALAFIL tablets, for oral use Initial U.S. Approval: 2003 | 20231110 |
| 30ae58ed-5b56-4513-8eb3-eb4f89b78f9d | tadalafil 2.5 MG Oral Tablet [PSN] · tadalafil 2.5 MG Oral Tablet [SCD] | 2 | 2 | These highlights do not include all the information needed to use TADALAFIL TABLETS safely and effectively. See full prescribing information for TADALAFIL TABLETS. TADALAFIL tablets, for oral use Initial U.S. Approval: 2003 | 20230322 |
| 48850075-ac57-abb7-e063-6394a90a7881 | tadalafil 2.5 MG Oral Tablet [PSN] · tadalafil 2.5 MG Oral Tablet [SCD] | 2 | 1 | These highlights do not include all the information needed to use TADALAFIL TABLETS safely and effectively. See full prescribing information for TADALAFIL TABLETS. TADALAFIL tablets, for oral use Initial U.S. Approval: 2003 | 20260116 |
| 2eae8756-5c7f-2545-e063-6294a90a6d52 | tadalafil 2.5 MG Oral Tablet [PSN] · tadalafil 2.5 MG Oral Tablet [SCD] | 2 | 1 | These highlights do not include all the information needed to use TADALAFIL TABLETS safely and effectively. See full prescribing information for TADALAFIL TABLETS. TADALAFIL tablets for oral use. Initial U.S. Approval: 2003 | 20250221 |
| add6afb8-d38c-47a2-8c35-d5940667bb0c | tadalafil 2.5 MG Oral Tablet [PSN] · tadalafil 2.5 MG Oral Tablet [SCD] | 2 | 1 | These highlights do not include all the information needed to use TADALAFIL TABLETS safely and effectively. See full prescribing information for TADALAFIL TABLETS. TADALAFIL tablets, for oral use Initial U.S. Approval: 2003 | 20241209 |
| 26a71650-63e1-cf1e-e063-6394a90ab938 | tadalafil 2.5 MG Oral Tablet [PSN] · tadalafil 2.5 MG Oral Tablet [SCD] | 2 | 1 | These highlights do not include all the information needed to use TADALAFIL TABLETS safely and effectively. See full prescribing information for TADALAFIL TABLETS. TADALAFIL tablets for oral use. Initial U.S. Approval: 2003 | 20241111 |
| 5ea24573-2d16-40d8-a46c-7b5fa8669e69 | tadalafil 2.5 MG Oral Tablet [PSN] · tadalafil 2.5 MG Oral Tablet [SCD] | 2 | 1 | These highlights do not include all the information needed to use TADALAFIL TABLETS safely and effectively. See full prescribing information for TADALAFIL TABLETS. TADALAFIL tablets, for oral use Initial U.S. Approval: 2003 | 20230328 |
| a3892605-4eb1-4d6e-a675-f7f7d4302f38 | tadalafil 2.5 MG Oral Tablet [PSN] · tadalafil 2.5 MG Oral Tablet [SCD] | 2 | 1 | These highlights do not include all the information needed to use TADALAFIL TABLETS safely and effectively. See full prescribing information for TADALAFIL TABLETS. TADALAFIL tablets, for oral use Initial U.S. Approval: 2003 | 20190326 |